Novozymes A/S (NVZMY) Stock Price & Analysis
Novozymes A/S (NVZMY) — price $66.01 (-0.29%), as of the Nov 18, 2026 trading session; market cap $30.8B.
Educational signal · not a buy or sell recommendation · How to read this
Novozymes A/S · NVZMY · Basic Materials · Chemicals - Specialty
Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics.
Price as of Nov 18, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $66.01 | |
| Change on the day | -0.29% | |
| 52-week range | $49.90–$75.27 | |
| Market capitalisation | $30.8B | — |
| Price / earnings (trailing) | 40.26 | |
| Shares traded on the day | 2.9K | |
| Beta (volatility vs the S&P 500) | 0.62 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Novozymes A/S (NVZMY): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 6 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 18, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Novozymes A/S (NVZMY), and what does it report?
Short answer
Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. Basic Materials / Chemicals Specialty SEC filing business address: Krogsho Jvej 36 2880 Bagsverd, Gladsaxe Denmark, G7, 00000. It employs 11,641 people and is led by Ester Baiget. The market values it at $30.8B.
What are the financial strengths and risks for Novozymes A/S (NVZMY)?
Short answer · as of
The distress and quality screens read Altman Z 23.95 · Piotroski F 5. Trailing ratios: ROE 6.2% · ROA 4.0% · current ratio 1.53 · earnings yield 2.4% · free-cash-flow yield 2.8%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held NVZMY in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported NVZMY in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Novozymes A/S (NVZMY)?
Common Questions About NVZMY (Basic Materials)
Research dated 2026-09-12; the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.
What does Novozymes sell to food and beverage producers?
It supplies ingredients and processing aids used in baking, beverages, dairy production, starch modification and protein applications. Management expects this business to lead the company’s organic sales growth.
Why do high comparables matter for Novozymes?
A demanding comparison base raises the hurdle for reported growth even when current demand remains constructive. Management has explicitly flagged that pressure alongside its margin outlook.
What is the NVZMY stock price today?
The last price recorded for Novozymes A/S (NVZMY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 15 figures on this page — 1 from SEC filings and earnings calls, 11 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com